Evaluation of the impact of hepatitis B vaccination in adults in Jiangsu Province, China

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Zhu, Liguo ^a,b   Zhai, Xiangjun ^b   Zhu, Yefei ^b   Xu, Weiguo ^b   Bao, Changjun ^b   Peng, Hong ^b   Bian, Qian ^b   Yang, Haitao ^b   Wang, Hua ^b   Hu, Zhibin ^a   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; AGE DISTRIBUTION; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CHINA; CROSS-SECTIONAL STUDY; FEMALE; HEALTH IMPACT ASSESSMENT; HEALTH SURVEY; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; POPULATION RESEARCH; PREVALENCE; PROGRAM IMPACT; RISK REDUCTION; SELF REPORT; SEROEPIDEMIOLOGY; EVALUATION STUDY; MIDDLE AGED; UTILIZATION; VACCINATION;

ADULT; CHINA; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; VACCINATION;

EID: 84903604506     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101501     Document Type: Article

References (25)

1. Wang YB, Chen EQ, Cui YL, Zeng L, Wang YJ, et al. (2011) Seroprevalence of hepatitis B virus markers in individuals for physical examination in West China Hospital, China. European review for medical and pharmacological sciences 15(6):592-596.
2. Chen P, Yu C, Ruan B, Yang S, Ren J, Xu W, et al.(2013) Prevalence of hepatitis B in insular regions of southeast China: a community-based study. PloS one 8(2):e56444.
3. Zhang H, Li Q, Sun J, Wang C, Gu Q, et al. (2011) Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China. International journal of medical sciences 8(4):321-331.
4. Li X, Zheng Y, Liau A, Cai B, Ye D, et al. (2012) Hepatitis B virus infections and risk factors among the general population in Anhui Province, China: an epidemiological study. BMC public health 12:272.
5. Leung N (2009) Chronic hepatitis B in Asian women of childbearing age. Hepatology international 3 Suppl 1:24-31.
6. Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of viral hepatitis 11(2):97-107.
7. Ganem D, Prince AM (2004) Hepatitis B virus infection - natural history and clinical consequences. The New England journal of medicine 350(11):1118-1129.
8. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiologic reviews 28:112-125.
9. Centers for Disease Control and Prevention (CDC) (2007) Progress in hepatitis B prevention through universal infant vaccination-China, 1997-2006. MMWR 56:441-445.
10. Liang XF, Chen YS, Wang XJ, He X, Chen LJ, et al. (2005) A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old. Chin J Epidemiol 26:655-658.
11. Hutton DW, So SK, Brandeau ML (2010) Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology 51(2):405-414.
12. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27(47):6550-7.
13. Liao SS, Li RC, Li H, Yang JY, Zeng XJ, et al. (1999) Long-term efficacy of plasma-derived hepati-tis B vaccine: a 15-year follow-up study among Chinese children. Vaccine 17:2661-6.
14. World Health Organization (2011) Progress towards meeting the 2012 hepatitis B control milestone: WHO Western Pacific Region, 2011. Wkly Epidemiol Rec 86(19):180-8.
15. Hyams KC (1995) Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20:992-1000.
16. Chinese Society of Hepatology, Chinese Society of Infectious Disease, Chinese Medical Association (2011) The guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J hepatol 19(1):13-24
17. WHO (2010) Vaccine-preventable diseases: monitoring system. 2010 global summary. WHO. Available: http://www.who.int/immunization/documents/who-ivb-2010/ en/. Accessed 2013 Noverber 25.
18. Zhou XL, Zhang Jun, Cao MQ (2003) Hepatitis B sero-epidemiology analysis in Tanxing city recent 13 years. Occupation and health 19(11):85-87
19. Du GM, Liu QF, Huang LF, et al. (2009) Sero-epidemiological surveys of hepatitis B in different populations in Zhangjiang city. Modern preventive medicine 36(23):4560-4562
20. Pereira LM, Martelli CM, Merchan HE, Montarroyos UR, Braga MC, et al. (2009) Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg 81(2):240-7.
21. Ott JJ, Stevens GA, Groeger J, Weirsma ST (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30(12): 2212-9.
22. Kew MC (2010) Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathologie-biologie 58(4):273-277.
23. McMahon BJ (2009) The natural history of chronic hepatitis B virus infection. Hepatology 49(5 Suppl):S45-55.
24. Baig S (2009) Gender disparity in infections of Hepatitis B virus. Journal of the College of Physicians and Surgeons - Pakistan 19(9):598-600.
25. Lu PJ, Byrd KK, Murphy TV, Weinbaum C (2011) Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009. Vaccine 29(40):7049- 7057.